The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

For patients with a lower BMI, gastric sleeve surgery can still be an option, but the outcomes and risks may differ from those with a higher BMI. Low-BMI patients often turn to the surgery to address health conditions like metabolic syndrome or diabetes rather than extreme obesity. Reviews from these patients often focus on the subtle, but significant, weight loss and the improvement in overall health. However, there are concerns that lower BMI patients might not experience the same dramatic results as those with... +More

Roux-en-Y (RNY) gastric bypass is a type of weight-loss surgery in which the stomach is divided into a small upper pouch and a larger lower "remnant" portion. The small intestine is rearranged to connect to both. This reduces the stomach's capacity and alters how the body absorbs calories and nutrients, making it one of the most effective bariatric surgeries for long-term weight loss. Patients can expect significant weight loss, but the procedure is more complex than other forms of bariatric surgery, requiring... +More

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.

Endoscopic sleeve gastroplasty is a newer type of minimally invasive weight-loss procedure. In endoscopic sleeve gastroplasty, a suturing device is inserted into your throat and down to your stomach. The endoscopist then places sutures in your stomach to make it smaller.